Jade Biosciences Inc (JBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -127,410 | -46,979 | -75,521 | -51,511 | -22,963 |
| Depreciation Amortization | -758 | N/A | -2,961 | -842 | 31 |
| Accounts payable and accrued liabilities | 361 | 1,290 | -164 | 1,368 | 609 |
| Other Working Capital | -8,197 | 10,509 | 9,798 | 7,755 | -6,510 |
| Other Operating Activity | 41,315 | 12,566 | 12,070 | 4,108 | 1,434 |
| Operating Cash Flow | $-94,689 | $-22,614 | $-56,778 | $-39,122 | $-27,399 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14,384 | N/A | 12,018 | 7,121 | -113,253 |
| PPE Investments | -196 | N/A | -142 | -195 | -181 |
| Purchase Of Investment | -261,194 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-247,006 | $N/A | $11,876 | $6,926 | $-113,434 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 360,228 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | 95,000 | N/A | N/A | N/A |
| Common Stock Issued | 384 | N/A | 46,230 | 767 | 126,945 |
| Other Financing Activity | 156 | -3,000 | -234 | -371 | 63,512 |
| Financing Cash Flow | $360,768 | $92,000 | $45,996 | $396 | $190,457 |
| Exchange Rate Effect | -21 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 69,386 | N/A | 22,397 | 54,197 | 4,573 |
| End Cash Position | 88,438 | 69,386 | 23,491 | 22,397 | 54,197 |
| Net Cash Flow | $19,052 | $69,386 | $1,094 | $-31,800 | $49,624 |
| Free Cash Flow | |||||
| Operating Cash Flow | -94,689 | -22,614 | -56,778 | -39,122 | -27,399 |
| Capital Expenditure | -196 | N/A | -142 | -195 | -181 |
| Free Cash Flow | -94,885 | -22,614 | -56,920 | -39,317 | -27,580 |